Related Experiment Videos
Thromboembolic disorders in cancer
Ruth Van Gerpen1, Merle E Mast
1ruth.vangerpen@bryanlgh.org
Clinical Journal of Oncology Nursing
|June 24, 2004
Summary
Cancer patients face thrombosis risks due to cancer cells, treatments, and immobility. This article details thrombosis causes, symptoms, diagnosis, and treatment, highlighting nurses' vital role in prevention and care coordination.
Area of Science:
- Oncology Nursing
- Hematology
- Thrombosis Management
Background:
- Cancer patients are at high risk for venous and pulmonary thromboembolism (VTE).
- Complex interactions between cancer, its treatments, and patient factors contribute to VTE risk.
- Chronic illness, immobility, and vessel injury exacerbate thrombosis risk in cancer patients.
Observation:
- This article reviews the etiology, clinical manifestations, diagnostic approaches, and therapeutic interventions for cancer-associated thrombosis.
- It emphasizes the critical role of oncology nurses in risk assessment, symptomatic management, and VTE prevention.
- The growing trend of outpatient cancer care underscores the need for nurses in coordinating VTE management.
Findings:
- Cancer itself, treatments like chemotherapy, and immobility are key drivers of thrombosis.
- Early identification and intervention are crucial for managing symptomatic VTE.
- Proactive nursing strategies are essential for primary and secondary VTE prevention in oncology settings.
Implications:
- Oncology nurses are pivotal in coordinating care and managing VTE risk in cancer patients, especially in outpatient settings.
- A comprehensive nursing care plan can enhance patient outcomes by addressing thrombosis assessment and intervention.
- Effective VTE management requires a multidisciplinary approach involving nurses, physicians, and other healthcare professionals.